Anti-GRIA3 antibody
Specifications
| Product Cat#: | AB-06-2038 |
| Product type: | Primary antibody |
| Antigen: | GRIA3 |
| Immunogen: | Purified recombinant fragment of human GRIA3 expressed in E. Coli. |
| Species immunized: | Mouse |
| Isotype: | IgG1 |
| Applications: | Western Blot (1:500-1:1000); Immunohistochemistry (1:50-1:200) |
| Reactivity: | Human, Rat |
| Clonality (clone number): | Monoclonal (E2-D1) |
| Form: | Liquid |
| Buffer: | 1*TBS (pH7.4), 1%BSA, 40%Glycerol. Preservative: 0.05% Sodium Azide. |
| Concentration: | 1 mg/ml |
| Purity: | Protein A affinity purified |
| Storage: | Aliquot and freeze at -20℃. Avoid multiple freeze/thaw cycles. |
| Alternative names: | AMPA 3 antibody |
| AMPA selective glutamate receptor 3 antibody | |
| AMPA-selective glutamate receptor 3 antibody | |
| dJ1171F9.1 antibody | |
| GluA3 antibody | |
| GLUK3 antibody | |
| GluR 3 antibody | |
| GLUR C antibody | |
| GLUR K3 antibody | |
| GluR-3 antibody | |
| GluR-C antibody | |
| GluR-K3 antibody | |
| GLUR3 antibody | |
| GLURC antibody | |
| Glutamate ionotropic receptor AMPA type subunit 3 antibody | |
| Glutamate receptor 3 antibody | |
| Glutamate receptor C antibody | |
| Glutamate receptor ionotrophic AMPA 3 antibody | |
| Glutamate receptor ionotropic antibody | |
| Glutamate receptor subunit 3 antibody | |
| Glutamate receptor, ionotropic, AMPA 3 antibody | |
| GRIA 3 antibody | |
| Gria3 antibody | |
| GRIA3_HUMAN antibody | |
| Ionotrophic Glutamate Receptor antibody | |
| MRX94 antibody |
Target information
Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.
Provider
Erpantech Laboratory
